Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Expensive Performer

607.3500 4.30 (0.71%)

NSE May 19, 2025 15:31 PM

57.57% Gain from 52W Low

Volume: 2.2M

Laurus Labs Ltd.

28 Nov 2019

607.35

0.71%

Laurus Labs (BUY): NDR takeaways

Buy: Laurus Labs Ltd.

BOB Capital Markets Ltd.

We recently hosted the management of Laurus Labs with investors. Overall, we found management's tone confident yet realistic.

Laurus Labs Ltd. is trading below its 30 day SMA of 610.1